[1]
“Application of the FMEA tool to analyze notifications of technical complaints about liquid medicines in the context of Quality by Design”, RSD, vol. 12, no. 6, p. e13012641992, Jun. 2023, doi: 10.33448/rsd-v12i6.41992.